Immunotherapy with interleukin-2 (IL2) and lymphokine-activated natural killer cells: improvement of clinical responses in metastatic renal cell carcinoma patients previously treated with IL2.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples